japanese korean simple chinese traditional chinese

Pre-Conference Workshop
Overview 
Day 1
Day 2
Distinguished Faculty
Register 
PDF Download
Hotel & Travel
Sponsor
Press Pass 
Request Brochure 

Complimentary Whitepaper

Partnering Best Practices for R&D Project Teams
William C. Ronco, Ph.D., President, Gathering Pace Consulting 

AppliedBiosystemsMDS logoPCC

Excel PharmaStudies

WilsonSonsini

Crownbio

Fountain Medical

ACRO

Asia Pacific

CABS

SABPA_2008

China Bio Accelerator

BioITWorld

Science AAAS

The Scientist

Asia Monitor

Business Monitor

Bio Outsourcing Asia

ChinaBio Today

China Business Review

Espicom

Future Pharmaceuticals

The Pink Sheet

The Pink Sheet Daily

Pharma Agreement News

PharmAsia News

Pharma_Company_Insight

Pharma Insight

Pharma China 

PharmaVoice

PharmaWeek

Reviews on Recent Clinical Trials

Thomson Reuters

Biolexis

CanBiotech

Pharmalicensing

PharmCast

SelectScience logo


Drug Development China


Conference Proceeding CD Now Available
  • Speaker Presentations
  • Poster Abstracts
  • and More!

Register Today! 

Li ChenA New Way to Discover Innovative Medicine: Approach from the East
Li Chen, Ph.D., Chief Scientific Officer, Roche R&D Center (China) Ltd 

Rickey PateAligning Business, Corporate, and International Tax Strategy
Rickey Pate, MBA, JD, Director of Global Tax, Eli Lilly and Company

Ji ZhangHow to Balance Internal and External Resources to Provide DMPK Support for Drug Discovery in China
Ji Zhang, Ph.D., Director, DMPK, GlaxoSmithKline R&D China

Ling ChenBuilding an Integrated Biomedical Institute for Innovative Medicine in China
Ling Chen, Ph.D., Director General, Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences

Guoxin ZhuDrug Discovery R&D in China: From Functional Capacity Outsourcing to Integrative  Partnership
Guoxin Zhu, Ph.D., Director, Discovery Chemistry Research & Technology, Eli Lilly & Company

Michael ShiAccelerate Oncology Clinical Development in Asia
Michael Shi, Ph.D., Director and Biomarker Project Leader, Exploratory Oncology Development, Novartis

Jun RenThe Latest Insights from China into Translational Research for Cancer
Jun Ren, M.D., Ph.D., Clinical Trials Coordination, Peking University School of Oncology/Beijing Cancer Hospital

Shaoyu ChenStrategic Planning for Clinical Development Operations in China: Legal and Regulatory Considerations
Shaoyu Chen, Senior Counsel, Development & Regulatory Law Group, Amgen Inc.

 Three Days of Interactive Discussions, Case Studies, Break-out Roundtables, and Panels

  • In-Licensing, Out-Licensing, and Risk Sharing: The China Landscape for Partnership Deals
  • Interactions and Initiatives Taken for Drug Development Between China and the Rest of Asia: A Focus on Oncology
  • Opportunities  for Drug Discovery in China: Chemistry, Biology, Integrated Projects, & Traditional Chinese Medicine
  • How to Conduct High Quality, Cost Effective GLP Safety Studies in China
  • Strategic Planning for Clinical Development Operations in China
  • Comparative Assessment of Regulatory Processes and Time Lines
  • The Role of Academic Clinical Trials Units for Drug Development in Asia
  • Business Model Case Studies: Real Challenges and Strategies to Harness R&D Capabilities in China
Pre-Conference Workshop - September 16, 2008
Improving China Drug Development Team Performance: Essential Partnering Strategies, Skills & Processes
Click here for full details on the pre-conference workshop.


On-Demand Webinar: The Impact of the Covance-WuXi Joint Venture
Click here to Listen to a pre-recorded webinar hosted by CHI's sister company, Cambridge Healthtech Associates (CHA), that was held on July 2, 2008.


During this complimentary, online session the following was discussed:
  • Why Covance and WuXi created this joint venture
  • How it may change pricing, services, and speed of growth in the pharma services sector in China
  • Implications on the competitive dynamics between providers (i.e. Bridge, WuXi, CRL-China,
    Medicilon-MPI, government labs, etc).



For questions about this conference, contact:
Micah Lieberman
Conference Director, Pharmaceutical Strategy Series
Cambridge Healthtech Institute
Tel: +1 541.482.4709
E-mail: mlieberman@pharmaseries.com

For partnership and sponsorship opportunities, contact:
Arnold Wolfson
Manager, Business Development
Cambridge Healthtech Institute
Tel: +1 781.972.5431
E-mail: awolfson@healthtech.com



By Series:
By Region:


Conference
& Course Catalog

CHI Catalog 


Short Course DVDs